Ether

Ether

SCHEMBL371586

CCOCC.Oc1ccc(-c2ccc(O)cc2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.58
ESR2 Q92731 4/20 0.58
MMP3 P08254 2/20 0.48
BCL2L1 Q07817 1/20 0.48
ABL1 P00519 2/20 0.46
ABCB1 P08183 2/20 0.46
BCR P11274 2/20 0.46
LTA4H P09960 1/20 0.46
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
CA7 P43166 1/20 0.45
HSD17B1 P14061 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
CYP3A4 P08684 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroquinone SCHEMBL925171 0.92 LTA4H (0.52) ESR1ESR2LTA4HCA12CA1
Hydroquinone SCHEMBL8536783 0.92 LTA4H (0.52) ESR1ESR2LTA4HCA12CA1
Hydroquinone SCHEMBL60032 0.92 LTA4H (0.52) ESR1ESR2LTA4HCA12CA1
Ether SCHEMBL1897483 0.91 MMP3 (0.65) ESR1ESR2MMP3BCL2L1ABL1
Ether SCHEMBL2211328 0.89 CYP3A4 (0.54) ESR1ESR2MMP3BCL2L1ABL1
Ether SCHEMBL9722615 0.87 ESR2 (0.63) ESR1ESR2ABL1ABCB1BCR
Hydroquinone SCHEMBL7891403 0.86 LTA4H (0.48) ESR1ESR2LTA4HCA12CA1
Hydroquinone SCHEMBL21647162 0.86 LTA4H (0.48) ESR1ESR2LTA4HCA12CA1
Hydroquinone SCHEMBL9418610 0.86 LTA4H (0.48) ESR1ESR2LTA4HCA12CA1
SCHEMBL27980931 0.86 ESR1 (0.48) ESR1ESR2MMP3BCL2L1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 611 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837237-B1 METHOD FOR THE PREPARATION OF A CYCLOALIPHATIC DIESTER COVESTRO DEUTSCHLAND AG (DE) 2024-04-24 EP claimed
US-11655202-B2 Process for preparing a cycloaliphatic diester COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2023-05-23 US claimed
US-20220119334-A1 PROCESS FOR PREPARING A CYCLOALIPHATIC DIESTER COVESTRO DEUTSCHLAND AG (DE) 2022-04-21 US claimed
WO-2021122509-A1 METHOD FOR THE PRODUCTION OF A POLYESTER CARBONATE COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2021-06-24 WO claimed
EP-3837237-A1 PROCESS FOR PREPARING A CYCLOALIPHATIC DIESTER Covestro Intellectual Property GmbH & Co. KG (DE) 2021-06-23 EP claimed
WO-2020035519-A1 PROCESS FOR PREPARING A CYCLOALIPHATIC DIESTER COVESTRO DEUTSCHLAND AG (DE) 2020-02-20 WO claimed
EP-1399498-A2 MELT POLYCARBONATE CATALYST SYSTEMS GENERAL ELECTRIC COMPANY (US) 2004-03-24 EP claimed
EP-1360221-A1 MELT POLYCARBONATE CATALYST SYSTEMS GENERAL ELECTRIC COMPANY (US) 2003-11-12 EP claimed
EP-1358246-A2 MELT POLYCARBONATE CATALYST SYSTEMS GENERAL ELECTRIC COMPANY (US) 2003-11-05 EP claimed
EP-1358247-A2 MELT POLYCARBONATE CATALYST SYSTEMS GENERAL ELECTRIC COMPANY (US) 2003-11-05 EP claimed
WO-2002055582-A2 MELT POLYCARBONATE CATALYST SYSTEMS GENERAL ELECTRIC COMPANY (US) 2002-07-18 WO claimed
WO-2002055585-A2 MELT POLYCARBONATE CATALYST SYSTEMS GEN ELECTRIC (US) 2002-07-18 WO claimed
WO-2002055584-A1 MELT POLYCARBONATE CATALYST SYSTEMS GENERAL ELECTRIC COMPANY (US) 2002-07-18 WO claimed
WO-2002055583-A2 MELT POLYCARBONATE CATALYST SYSTEMS GENERAL ELECTRIC COMPANY (US) 2002-07-18 WO claimed
US-6395862-B1 CONTACTING DIARYLOXY COMPOUND WITH DIHYDRIC PHENOL IN THE PRESENCE OF ALKALI METAL TRIAZINE PYRIDYL SULFONATE, CARBOXY OR PHOSPHONATE GENERAL ELECTRIC COMPANY 2002-05-28 US claimed
US-6376640-B1 USING CESIUM POLYMERIZATION CATALYST GENERAL ELECTRIC COMPANY 2002-04-23 US claimed
US-6323304-B1 CONTACTING A DIARYLOXY COMPOUND WITH A DIHYDRIC PHENOL COMPOUND IN THE PRESENCE OF CATALYST COMPRISED OF ALKALI OR ALKALINE EARTH METAL-TRANSITION METAL FLUORIDE COMPOUND AND IN PRESENCE OF COCATALYST GENERAL ELECTRIC COMPANY 2001-11-27 US claimed
US-6323303-B1 POLYMERIZING DIARYLOXY COMPOUND WITH A DIHYDRIC PHENOL COMPOUND IN THE PRESENCE OF A RUTHENIUM (II) OR RUTHENIUM (III) COMPOUND OR COMPLEX; OPTIONALLY IN PRESENCE OF A TETRAALKYL AMMONIUM OR TETRAALKYL PHOSPHONIUM SALT GENERAL ELECTRIC COMPANY 2001-11-27 US claimed
US-6303737-B1 POLYCONDENSATION CATALYSTS WHICH ARE SALTS OF CERTAIN PHENANTHROLINE COMPOUNDS; EXCELLENT POLYMERIZATION RATES; REDUCING THE LEVEL OF BRANCHING SIDE REACTION, I.E., FORMATION OF FRIES PRODUCT GENERAL ELECTRIC COMPANY 2001-10-16 US claimed
US-6291631-B1 CONTACTING DIARYLOXY COMPOUND WITH A DIHYDRIC PHENOL COMPOUND IN THE POLYMERIZATION CATALYST UNDER POLYCARBONATE MELT POLYMERIZATION CONDITIONS GENERAL ELECTRIC COMPANY 2001-09-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119334-A1 PROCESS FOR PREPARING A CYCLOALIPHATIC DIESTER DECR1, DECR2, DHCR7 ESR1 4030/4885ESR2 3301/4885MMP3 3501/4885
US-11655202-B2 Process for preparing a cycloaliphatic diester DECR1, DECR2, DHCR7 ESR1 4030/4885ESR2 3301/4885MMP3 3501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.